Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Even though Pacific Biosciences of California, Inc. (NASDAQ:PACB) has fallen by 12% over the past week , insiders who sold US$3.1m worth of stock over the past year have had less luck. Insiders might

Simply Wall StJun 15 09:56 ET

PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database

Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease ResearchMENLO PARK, Calif., June 10, 2024 /PRNewswire/ -- PacBio

Pacific Biosciences of CaliforniaJun 10 00:00 ET

Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB) in the last three months.The table below summarizes their rec

BenzingaJun 3 15:00 ET

Express News | Jefferies Initiates Coverage On Pacific Biosciences With Buy Rating, Announces Price Target of $4

BenzingaJun 3 14:23 ET

Express News | Pacific Biosciences of California Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $4

ReutersJun 3 01:43 ET

Reasons to Retain PacBio (PACB) Stock in Your Portfolio

Yahoo FinanceMay 29 13:00 ET